This study is looking at whether e-cigarettes can help people quit smoking, compared to traditional methods like nicotine replacement therapy (NRT) or varenicline (Chantix). You might be able to join if you are 21 or older, have tried to quit smoking before using FDA-approved medications, and are interested in reducing harm from tobacco or quitting. Participants will be randomly assigned to one of two groups: one receiving e-cigarettes or one receiving FDA-approved medication (NRT or varenicline). The main goal is to see how many people successfully quit smoking for at least 7 days at 11 weeks. The study plans to enroll 225 people, but its current status is unclear.

Study design

This is an interventional study, meaning participants will receive a specific intervention. You will be randomly assigned to one of two groups: e-cigarette or medication, with a planned enrollment of 225 participants.

What's involved

Participation will last 6 months. This includes weekly phone calls for the first 7 weeks, an 11-week phone call, and a 6-month follow-up visit.

Compensation

Not stated in the trial record.

Follow-up

Participants will have a 6-month follow-up visit after the initial 11-week assessment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.